American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.
about
Off-trial evaluation of bisphosphonates in patients with metastatic breast cancerAromatase inhibitors in the treatment of endometriosisSurveillance and Care of the Gynecologic Cancer SurvivorImplementing the exercise guidelines for cancer survivorsExposure to bisphosphonates and risk of colorectal cancerMenopausal symptoms in young survivors of breast cancer: a growing problem without an ideal solutionDiagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation OncologyPersonalized assessment and management of women at risk for breast cancer in North AmericaThe effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeletonAdvancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference.Cancer treatment-related bone disease.Prevention, diagnosis and treatment of osteoporosis following menopause induced due to oncological disease.American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.Use of intravenous bisphosphonates in older women with breast cancerRecurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life.Assessment of fracture risk in women with breast cancer using current vs emerging guidelines.Comparison of the efficacy and safety of denosumab versus bisphosphonates in breast cancer and bone metastases treatment: A meta-analysis of randomized controlled trials.Update in new medications for primary care.Status of adjuvant endocrine therapy for breast cancer.Platelet-Rich Plasma in Treatment of Zoledronic Acid-Induced Bisphosphonate-related Osteonecrosis of the Jaws.Managing aromatase inhibitors in breast cancer survivors: not just for oncologistsBisphosphonate-related osteonecrosis of the jaw: historical, ethical, and legal issues associated with prescribing.The evolving role of zoledronic acid in early breast cancerRecent developments in bisphosphonates for patients with metastatic breast cancer.A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites.Potential role of aromatase inhibitors in the treatment of endometriosisZoledronic acid and skeletal complications in patients with solid tumors and bone metastases: analysis of a national medical claims databaseIncreased fracture rate in women with breast cancer: a review of the hidden risk.Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targetsHigh prevalence of low vitamin D and musculoskeletal complaints in women with breast cancer.Caring for the breast cancer survivor's health and well-being.Update on estrogens and the skeletonOral bisphosphonate use and breast cancer incidence in postmenopausal women.Adjuvant Endocrine Therapy in Early Postmenopausal Breast CancerRisk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRNAromatase inhibitors in post-menopausal endometriosis.Management options of breast cancer related osteoporosis.Predicting skeletal complications in metastatic breast cancer raises challenges.Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals.Patterns of bone density evaluation in a community population treated with aromatase inhibitors.
P2860
Q24811840-E4D975BF-2E1E-41B7-A412-9BA03E621D5CQ26751946-0A412F57-72F1-43C1-9582-2F246AEE3644Q26799810-72BA90B0-FD5D-4DBA-B4B1-F0AF754311F3Q27003664-2BFE25DF-8051-4D59-8329-D8067B1EB3ABQ27022446-683C95C1-DECD-42FD-994D-5ACB897A65B3Q27025094-B8060AE4-178E-4703-8CBF-B0B9D705CEC7Q28076646-C9B29393-1B71-4969-BC4C-C7162FFF3419Q28083876-10F88D17-F40D-4E31-8B4F-DB34B7AF9987Q28539057-5658DF5C-18FB-407E-83F7-FCD4829C2249Q30438167-B8C115C1-743A-49F5-B0F8-3D6C2B501C2AQ30438185-13AB9AF0-D7B4-422D-A992-E697813A7111Q33610328-A3F8663A-04C0-4BF4-A1D0-211E8BE66D4CQ33631047-73B6CC78-40F2-4AAB-B19F-54A70D6778BAQ33666930-7911AFAE-2475-45C7-B1B5-DCF8C765DC34Q33703527-49815BD7-D972-4527-9D71-DDDA4CA3C868Q33723674-87B12F0F-DCC8-4638-8ED1-FF5D9F9A6BA7Q33727640-812DE351-7CD9-48BE-9075-ABAA58B5E6FBQ33730845-DFBDE34F-442C-4DC1-BB2E-A1136E471E9CQ33739138-4732C978-D78B-4BD8-A7C4-11C0BC503E0DQ33841355-921EE7A2-C700-476F-AEF2-31B69FFAF415Q33884184-A2BA5FED-3E29-4BD1-B4E5-B510EF51F378Q33885770-B5FD52FA-9CEB-4DA3-98E1-E3F9BC4E822BQ33915978-83E9BC7C-C056-440D-A6B4-7BEDE7E4BA2BQ33935632-9567A8EC-CD0D-49B8-B4A4-9CEE9DF9815BQ33941303-C1BC154A-3BEB-413F-A310-6134D4E5D09BQ33961506-6BD2E51D-9CFA-4EE8-B400-CF152470AC1AQ33978299-F95649B1-A44F-4F41-B975-FAE624D0FC88Q34004925-D3C2C7D2-29FC-48B2-838F-910AA477C4A7Q34023663-AD88DFC8-DEA4-4542-9489-DF98C907C177Q34024686-CAD57F74-1505-470D-932B-697AC5639A09Q34031251-147049F2-E145-481F-B19B-FA914B57D33CQ34031994-452201AE-E5E9-48B9-9CA7-8865FEE567C0Q34049239-5F41C5D7-2CEB-42C8-BF8D-DAE9465D4FBCQ34096283-19236B70-5291-403D-AC60-96AA6FA24C34Q34164223-7CFCF4B8-8563-4C93-A2FB-C43C3DCD4F9EQ34194386-4BED37E4-5018-482F-A292-86A400BDF669Q34230292-5C599E03-9290-4024-9D13-7E5BA64FB79FQ34247639-F01FC67A-67A2-4CA7-A6E4-D139DD7AAE65Q34266960-25103CA2-BDC3-4E21-941A-585F2D18EB96Q34335213-3E3FCAEE-5A16-4C06-AFF9-2998A217FA6B
P2860
American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
American Society of Clinical O ...... s in women with breast cancer.
@en
American Society of Clinical O ...... s in women with breast cancer.
@nl
type
label
American Society of Clinical O ...... s in women with breast cancer.
@en
American Society of Clinical O ...... s in women with breast cancer.
@nl
prefLabel
American Society of Clinical O ...... s in women with breast cancer.
@en
American Society of Clinical O ...... s in women with breast cancer.
@nl
P2093
P356
P1476
American Society of Clinical O ...... s in women with breast cancer.
@en
P2093
Allan Lipton
Brent A Blumenstein
Bruce E Hillner
Gary C Yee
James N Ingle
Julie Gralow
Kathy S Albain
Nora A Janjan
Rowan T Chlebowski
Susan Brown
P304
P356
10.1200/JCO.2003.08.017
P407
P577
2003-09-08T00:00:00Z